Drug Trial Radar · NCT06809218
A Pooled Analysis of Long-Term Outcomes After Inhaled Isoflurane Via the Sedaconda ACD-S Compared to Intravenous Propofol
Last checked: Nov 20, 2026Latest source record: Feb 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
312
Planned (sponsor's estimate)
Start
Apr 22, 2022
Primary completion
Nov 14, 2024
Study completion Jan 30, 2025
Sponsor
- Lead sponsor
- Sedana MedicalIndustry
- Sponsor type
- Industry
- Collaborators
- Critical Illness, Brain Dysfunction, and Survivorship Center
- First posted
- Feb 5, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This pooled analysis will assess Cognitive, Mental Health, Functioning, and Quality of Life Assessments data from the Phase 3 registration studies INSPiRE-ICU 1 (NCT05312385) and INSPiRE-ICU 2 (NCT05327296) to explore potential differences in Long-Term Outcomes at 3 and 6 months after treatment between critically ill mechanically ventilated patients sedated with inhaled isoflurane compared to sedated with intravenous propofol. The analyses were pre-planned and agreed prior to completion of enrollment of either study.
Conditions
- Post-Intensive Care Syndrome
- Sedation
Interventions
Inhaled isoflurane administered by Sedaconda ACD-SDrug
Intervention: isoflurane
Intravenous infusion of propofolDrug
Intervention: propofol
Primary outcomes
What the sponsor says the trial is designed to measure.
- To compare cognitive function 3 months post randomization in isoflurane- vs propofol-treated patientsTime frame: 3 months post Randomization
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The Critical Illness, Brain Dysfunction and Survivorship (CIBS) Center
Nashville, Tennessee
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.